TD Cowen Begins Coverage on KindlyMD (NASDAQ:NAKA)

Key Points

• TD Cowen initiated coverage with a Buy rating and a $1 price target, implying roughly a 375% upside from the current share price.
• Analyst views are mixed — three Buys, one Hold and one Sell — leaving a consensus rating of "Hold" and an average price target of $0.75, with several firms recently trimming targets.
• The stock trades around $0.21 (market cap ≈ $145M) after a volatile year (52‑week high $34.77), and a handful of institutions made small new Q4 purchases totalling well under $600k.

Equities researchers at TD Cowen began coverage on shares of KindlyMD (NASDAQ:NAKA - Get Free Report) in a report issued on Friday. The firm set a "buy" rating and a $1.00 price target on the stock. TD Cowen's target price would indicate a potential upside of 375.06% from the stock's current price.

Several other analysts also recently weighed in on the company. B. Riley Financial decreased their target price on KindlyMD from $1.00 to $0.50 and set a "buy" rating for the company in a research note on Monday, February 23rd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of KindlyMD in a research report on Friday, March 27th. Finally, Maxim Group cut their price target on KindlyMD from $1.50 to $0.75 and set a "buy" rating for the company in a report on Monday. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $0.75.

KindlyMD Price Performance

NAKA stock opened at $0.21 on Friday. The stock has a market capitalization of $145.25 million, a price-to-earnings ratio of -0.24 and a beta of 26.73. The company has a 50-day moving average of $0.26 and a two-hundred day moving average of $0.51. KindlyMD has a 52-week low of $0.21 and a 52-week high of $34.77.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Sagespring Wealth Partners LLC acquired a new stake in KindlyMD during the fourth quarter worth about $28,000. SG Americas Securities LLC acquired a new position in KindlyMD in the 4th quarter valued at approximately $61,000. Virtu Financial LLC acquired a new position in KindlyMD in the 4th quarter valued at approximately $151,000. J. Derek Lewis & Associates Inc. bought a new stake in shares of KindlyMD in the 4th quarter worth approximately $167,000. Finally, Truist Financial Corp bought a new stake in shares of KindlyMD in the 4th quarter worth approximately $176,000.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.